CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
9.70
+0.06 (0.58%)
Nov 21, 2024, 1:54 PM EST - Market open
CervoMed Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -11.95 | -2.17 | -5.8 | -4.14 |
| Stock-Based Compensation | 1.23 | 0.41 | 0.46 | 0.96 |
| Other Operating Activities | - | -5.42 | 2.39 | -0.9 |
| Change in Accounts Payable | 0.6 | 0.57 | 0.08 | -0.15 |
| Change in Other Net Operating Assets | 0.46 | -0.83 | 0.3 | 0.1 |
| Operating Cash Flow | -11.02 | -7.45 | -2.57 | -4.13 |
| Long-Term Debt Issued | - | - | - | 6 |
| Net Debt Issued (Repaid) | - | - | - | 6 |
| Issuance of Common Stock | 46.4 | 0.81 | - | - |
| Other Financing Activities | -0.09 | 10.34 | - | - |
| Financing Cash Flow | 46.31 | 11.15 | - | 6 |
| Net Cash Flow | -2.68 | 3.7 | -2.57 | 1.87 |
| Free Cash Flow | -11.02 | -7.45 | -2.57 | -4.13 |
| Free Cash Flow Margin | -109.46% | -104.27% | - | - |
| Free Cash Flow Per Share | -1.48 | -2.80 | -4.97 | -0.92 |
| Levered Free Cash Flow | -6.64 | -4.23 | -1.33 | - |
| Unlevered Free Cash Flow | -6.64 | -4.23 | -1.33 | - |
| Change in Net Working Capital | -0.05 | 0.25 | -0.38 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.